Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  yttrium Y 90 glass microspheres
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-19 of 19 for your search:
Start Over
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TS-102, NCT01483027
Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TS-103, NCT01556490
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TS-104, 2012-005375-14, NCT01887717
Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000069336, PCI-IRB-0611014, PCI-IRB-000656, PCI-IRB-000871, NCI-V02-1701, NCT00039078
Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 1365-002, P30CA060553, NCT00532740
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: STU 12339, P30CA060553, STU# 00012339, CDR0000651416, NU-09I2, IRB# STU00012339, NCT00956930
Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and ove
Sponsor: Other
Protocol IDs: 2011/050, NCT01381211
SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10D.95, NCT01473004
Response of Hepatic Tumors to Radioembolization
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: USZ-ZH-VIS-RESRAD, NCT01775280
Definitive Therapy for Oligometastatic Solid Malignancies
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Carter 2005-01, 1073869, NCT01898962
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-EB-CHOL-Th, 2012-001213-16, A121007-71, NCT01912053
Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHUV-CePO-code 16295, NCT01893099
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 1365-001, P30CA060553, NCT00530010
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-029 TheraSphere®, NCT00877136
TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCI 01-61, CA60396, 2002-2242, NCT00906984
Humanitarian Device Exemption (HDE) Treatment Protocol
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0770, NCI-2010-01956, NCT01176604
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07D.366, 2007-49, NCT01349075
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
Phase: No phase specified
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: XHEP0016-NOT-RESEARCH, HEP0016, 14324, NCT01076517
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-10036, NCI-2012-00877, NCT02072356
Start Over